PHILADELPHIA, Dec. 7, 2005 (PRIMEZONE) -- Because of sold out attendance at last year's Glitter City Gala, NYEphilly.com introduces the Atomic Ball -- a second option for Philadelphia's New Year's Eve revelers. These events target young professionals, ages 23-40+ looking for an evening to remember. A portion of event proceeds will be donated to the Sandy Rollman Ovarian Cancer foundation, plus additional cancer charities.

HOUSTON, Dec. 7, 2005 (PRIMEZONE) -- Thirteen-month-old Taylor Forbes, who has spent all but three weeks of her life at Texas Children's Hospital, has a very short list for Santa this year. She wants a donor heart.

HOUSTON, Dec. 7, 2005 (PRIMEZONE) -- Quest Oil Corporation (OTCBB:QOIL) subsidiary Quest Canada Corp. is pleased to report gas production at the Acadia North well "10-22" totaled 64.5 mmcf for an average of 2.15 mmcfpd for November, representing an increase of 13% month-over-month.

NEW YORK, Dec. 7, 2005 (PRIMEZONE) -- Parker & Waichman, LLP (http://www.yourlawyer.com) announced that it has filed suit against Ortho-McNeil Pharmaceutical, Inc., a division of Johnson and Johnson Inc. (NYSE:JNJ), on behalf of a 27-year-old woman who suffered a deep venous thrombosis (DVT) after using the Ortho Evra contraceptive patch for 12 months. In December 2003, the Plaintiff began experiencing increasing swelling, warmth and pain in her left lower extremity. The pain intensified and on December 22, 2003, the Plaintiff was taken to the emergency room at Eliza Coffee Memorial Hospital in Florence, Alabama. A Doppler venogram was performed which revealed a deep venous thrombosis in the distal half of the left peroneal vein. As a result, the plaintiff was admitted to the hospital for Heparin and Coumadin (anticoagulant) therapy. The plaintiff will likely undergo prolonged treatment with these medications, which may be necessary for the remainder of her life. The suit was filed on December 2, 2005, in the United States District Court for the District of New Jersey in Newark, New Jersey. For more information on Ortho Evra please visit www.orthopatchlawsuit.com or http://www.yourlawyer.com/practice/overview.htm?topic=Ortho%20Evra%20Patch.

PALATINE, Ill., Dec. 7, 2005 (PRIMEZONE) -- "Making Mail Fun Again" is the goal behind the new Photo Pocket Postcard(tm) that lets you create postcards with any photo of your choice. You can make your mail more than an impersonal note or card by simply inserting a photo.

NEW YORK, Dec. 7, 2005 (PRIMEZONE) -- Bioaccelerate Holdings Inc. (OTCBB:BACL) today announced that its portfolio company, Enhance Biotech Inc. (Pink Sheets:EBOI), a Specialty Pharmaceutical company that acquires, develops and seeks to commercialize drugs primarily in the Lifestyle Drug market, has today announced that it has received clearance from the FDA to proceed with Phase 1 clinical trials for its proprietary selective delta agonist, DPI-221, for urge and mixed Urinary Incontinence (UI). This is a novel mechanism for the potential treatment of UI.

RESEARCH TRIANGLE PARK, N.C., Dec. 7, 2005 (PRIMEZONE) -- Enhance Biotech Inc. (Pink Sheets:EBOI), a Specialty Pharmaceutical company that acquires, develops and seeks to commercialize drugs primarily in the Lifestyle Drug market, today announced that it has received clearance from the FDA to proceed with Phase 1 clinical trials for its propriety selective delta agonist, DPI-221, for urge and mixed Urinary Incontinence (UI). This is a novel mechanism for the potential treatment of UI.

CHESTER, Penn., Dec. 7, 2005 (PRIMEZONE) -- StudyAbroad.com, an education company that publishes a comprehensive online directory of study abroad programs, has decided to use its resources and experience to create an interactive travelogue for students and tourists that will offer the most current travel information available.

Easily Send & Share Press Releases

GlobeNewswire, a NASDAQ OMX company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.